中文

← All funding rounds

Mithrl

United StatesScience models and AI scientistsSan Francisco, United StatesFounded 2023Private

Website · mithrl.com ↗

Builds a knowledge base from decades of peer-reviewed biomedical studies, keeping what each finding measured and perturbed, and an agentic layer over the frontier models a drug company already uses, so its scientists can judge which hypotheses survive the next experiment; deployed inside the customer's own environment and extended with their data.

Disclosed total$20M
Rounds on record1
Latest round$20MSeries A · 2026-09-15
Last stated valuationNone stated
Investors named3
Research on recordNone yet

Money and evidence

Moneyeach round in US dollars; ≈ converted at its date$20M
Closed round

No research by this company is on the record yet.

Rounds and research, on one timeline

  1. 2026-09-15Series A
    Round

    $20M

    For: the second generation of its platform, Mithrl-1; hiring for deployments inside large drug companies; expansion across therapeutic areas including immunology, oncology, diabetes, metabolic and cardiovascular disease

    Models and platformHiringCommercial roll-out

    CEO Vivek Adarsh gave the amount and the investors to GEN; the company's own post of the same day announces the raise without naming a sum. The release also names several unnamed pharma executives as participants, so they are not listed. No valuation and no cumulative total. Business Wire returned 403 to both fetch paths.

    Lead · Obvious Ventures ✓HeadlineAGI House

    On the deal: Rohan Ganesh (Partner; his own firm page says he led the investment, Obvious Ventures)

    The investor's own page says · Obvious Ventures: Partner Rohan Ganesh's page: "Rohan has led investments in Inceptive, AMI Labs, Ataraxis, Inductive Bio, Synteny, Mithrl"

    Announced by the company · genengnews.com ↗On the timeline →

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →

On the investors' own sites

Investors that name this company on their own site, in a portfolio or their own announcement. A ✓ in a round marks the same investor.

  • Obvious VenturesPartner Rohan Ganesh's page: "Rohan has led investments in Inceptive, AMI Labs, Ataraxis, Inductive Bio, Synteny, Mithrl" · Leadobvious.com ↗

Its investors also backed

Other companies on this page whose rounds name the same investor.